TCMBANKIN059002 |
Grayanotoxin I |
ACon0_000384; 135912-EP2277880A1; MEGxp0_001761; Acetylandromedol; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate; G-I; NP-010017; NCGC00168796-02_C22H36O7_Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R,16alpha)-; GRAYANOTOXIN I; ZINC3978484; NCGC00168796-01; Grayanotoxane-3,5,6,10,14,16-hexol 14-acetate; 4720/9/6; SCHEMBL3229044; GTX-I; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol-, dodecahydro-1,1,4,8-tetramethyl-, 12-acetate, (2S,3aS,4aR,7R,8R,9aS,11R,11aR,12R)-; HSDB 3463; 135912-EP2292610A1; Rhodotoxine; Rhodotoxin; Asebotoxin; W4E6HC3T2B; BRN 2065643; Perhydro-2beta,4alpha,8alpha,11beta,11abeta-pentahydroxy-1,1,4,8-tetramethyl-7,9a-methano-9aalphaH-cyclopenta(b)heptalen-12beta-yl acetat; Andromedotoxin; UNII-W4E6HC3T2B; CHEMBL3085397; Grayanotoxane-3,5,6,10,14,16-hexol, 14-acetate, (3beta,6beta,14R)- (9CI); ACon1_000099; AKOS027326735; CHEBI:5542; AK322338; Perhydro-2beta,4alpha,8alpha,11beta,11abeta-pentahydroxy-1,1,4,8-tetramethyl-7,9a-methano-9aalphaH-cyclopenta(b)heptalen-12beta-yl acetate; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodecahydro-1,1,4,8-tetramethyl-, 12-acetate (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; NSC 26711; (14R)-3beta,5,6beta,10,16-pentahydroxygrayanotoxan-14-yl acetate; C09103; 4720-09-6 |
C22H36O7 |
412.5 g/mol |
CC(=O)OC1C2CCC3C1(CC(C4(C(C3(C)O)CC(C4(C)C)O)O)O)CC2(C)O |